Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor (2019)

ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitorMaria Menichincheri*Maria Menichincheri*E-mail: [email protected]More by Maria Menichincheri, Elena ArdiniElena ArdiniMore by Elena Ardini, Paola MagnaghiPaola MagnaghiMore by Paola Magnaghi, Nilla AvanziNilla AvanziMore by Nilla Avanzi, Patrizia BanfiPatrizia BanfiMore by Patrizia Banfi, Roberto BossiRoberto BossiMore by Roberto Bossi, Laura BuffaLaura BuffaMore by Laura Buffa, Giulia CanevariGiulia CanevariMore by Giulia Canevari, Lucio CerianiLucio CerianiMore by Lucio Ceriani, Maristella ColomboMaristella ColomboMore by Maristella Colombo, Luca CortiLuca CortiMore by Luca Corti, Daniele DonatiDaniele DonatiMore by Daniele Donati, Marina FasoliniMarina FasoliniMore by Marina Fasolini, Eduard FelderEduard FelderMore by Eduard Felder, Claudio FiorelliClaudio FiorelliMore by Claudio Fiorelli, Francesco FiorentiniFrancesco FiorentiniMore by Francesco Fiorentini, Arturo GalvaniArturo GalvaniMore by Arturo Galvani, Antonella IsacchiAntonella IsacchiMore by Antonella Isacchi, Andrea Lombardi BorgiaAndrea Lombardi BorgiaMore by Andrea Lombardi Borgia, Chiara MarchionniChiara MarchionniMore by Chiara Marchionni, Marcella NesiMarcella NesiMore by Marcella Nesi, Christian OrreniusChristian OrreniusMore by Christian Orrenius, Achille PanzeriAchille PanzeriMore by Achille Panzeri, Enrico PesentiEnrico PesentiMore by Enrico Pesenti, Luisa RusconiLuisa RusconiMore by Luisa Rusconi, Maria Beatrice SaccardoMaria Beatrice SaccardoMore by Maria Beatrice Saccardo, Ermes VanottiErmes VanottiMore by Ermes Vanotti, Ettore PerroneEttore PerroneMore by Ettore Perrone, and Paolo OrsiniPaolo OrsiniMore by Paolo OrsiniCite this: J. Med. Chem. 2019, 62, 17, 8364Publication Date (Web):August 19, 2019Publication History Published online19 August 2019Published inissue 12 September 2019https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01259https://doi.org/10.1021/acs.jmedchem.9b01259correctionACS PublicationsCopyright © 2019 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views2652Altmetric-Citations3LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (176 KB) Get e-Alertsclose Get e-Alerts